Advances in Hematological Malignancies

Recent years have witnessed remarkable advancements in the domain of hematological malignancies. Novel approaches such as targeted agents, immunotherapies, and gene editing are altering the survival rates for patients with blood cancers. Ongoing investigations continue to explore these innovative strategies, offering potential for more curative tre

read more